Skip to main content
ManuSights

Reference notes

Coverage

57 journal policy records

Sources

Feb. 2026 publisher snapshot · JCI rechecked Sep. 2026

Last reviewed

Dataset: February 2026 · JCI record: September 2026

Prepared by the Manusights editorial team.

Preprint-policy guide

Preprints in Biomedicine: bioRxiv, medRxiv, and Journal Preprint Policies

Preprints are now a routine part of many biomedical workflows, but journal rules, clinical screening, and funder obligations still make the decision context-specific. If you're unsure whether to post one or how it affects a target journal, this guide helps you start the check.

Quick orientation

Use this page when the real question is whether posting a preprint will help, hurt, or complicate the journal plan.

This guide is for the decision stage: whether to post, which server fits the manuscript, what the target journal expects you to disclose, and where the rare exceptions still exist.

57 journal policiesbioRxiv and medRxiv guidanceDisclosure expectationsBest for submission timing

7

Actively encouraged

50

Allowed

0

Allowed with conditions

0

Not allowed

What Is a Preprint and Why It Matters

A preprint is a version of a manuscript posted publicly before peer review. It gets a timestamp and a DOI through a preprint server (bioRxiv for life sciences, medRxiv for clinical/health sciences), making it citable and shareable immediately.

Preprints don't replace peer review, they run alongside it. You post the preprint, then submit to a journal. The journal reviews it independently. If accepted, the preprint stays up alongside the published version.

NIH recognizes preprints as interim research products in specified applications and reports, and its Preprint Pilot improves discoverability of selected NIH-supported preprints. That is separate from the public-access requirement for a peer-reviewed article.

Establishes priority: A timestamped DOI proves you had the finding before others, which matters in competitive research areas
Gets community feedback: Other researchers can comment before submission, improving the manuscript
Immediate visibility: Your work can be read and cited while it sits in peer review (which can take months)
NIH discovery and reporting: NIH recognizes preprints as interim research products in some reporting contexts, but they do not replace the public-access obligation for a peer-reviewed article
Career benefit: Preprint DOIs can be listed on CVs, grant applications, and job materials before formal publication

bioRxiv vs medRxiv: Which One?

bioRxiv

Cold Spring Harbor Laboratory. For life sciences broadly: molecular biology, cell biology, genetics, neuroscience, immunology, biochemistry, genomics, evolutionary biology. The default preprint server for most basic research.

biorxiv.org | Free to post

medRxiv

Cold Spring Harbor Laboratory + Yale + BMJ. For health sciences, clinical medicine, epidemiology, public health, and clinical trials. Use medRxiv if your work involves patient data, clinical outcomes, or health policy implications.

medrxiv.org | Free to post | Additional screening for clinical content

medRxiv caution: medRxiv adds a brief screening check for clinical manuscripts that could affect patient behavior. Papers involving clinical trials, drug efficacy, or public health recommendations take slightly longer to appear (~1–2 days). This is by design.

Preprint policies for biomedical journals

Search journals, policy status, preferred preprint servers, and disclosure notes. Export the current view or copy rows into a lab submission guide or publishing policy sheet.

JournalPolicyPreferred server
NatureAllowedbioRxiv / any
ScienceAllowedbioRxiv / any
CellAllowedbioRxiv / any
The LancetAllowedmedRxiv preferred
NEJMAllowedmedRxiv
JAMAAllowedmedRxiv
Nature MedicineAllowedbioRxiv / medRxiv
The BMJEncouragedmedRxiv
Cancer CellAllowedbioRxiv / medRxiv
Journal of Clinical OncologyAllowedmedRxiv
The Lancet OncologyAllowedmedRxiv preferred
JAMA OncologyAllowedmedRxiv
CirculationAllowedmedRxiv
European Heart JournalAllowedmedRxiv / bioRxiv
JACCAllowedmedRxiv
JAMA CardiologyAllowedmedRxiv
Circulation ResearchAllowedbioRxiv / medRxiv
Nature NeuroscienceAllowedbioRxiv
NeuronAllowedbioRxiv
BrainAllowedbioRxiv / medRxiv
Lancet NeurologyAllowedmedRxiv
Molecular PsychiatryAllowedbioRxiv / medRxiv
Journal of NeuroscienceAllowedbioRxiv
Cell MetabolismAllowedbioRxiv
Cell Host & MicrobeAllowedbioRxiv
Cell Stem CellAllowedbioRxiv
Molecular CellAllowedbioRxiv
Developmental CellAllowedbioRxiv
Current BiologyAllowedbioRxiv
Cell ReportsAllowedbioRxiv
PNASAllowedbioRxiv / any
Nature CommunicationsAllowedbioRxiv / any
Science AdvancesAllowedbioRxiv / any
eLifeEncouragedbioRxiv / medRxiv
PLOS ONEEncouragedbioRxiv / any
Scientific ReportsAllowedbioRxiv / any
Nature GeneticsAllowedbioRxiv
Nature MethodsAllowedbioRxiv
Genome BiologyEncouragedbioRxiv
Nucleic Acids ResearchAllowedbioRxiv / any
Nature Structural & Molecular BiologyAllowedbioRxiv
Nature Chemical BiologyAllowedbioRxiv / ChemRxiv
The EMBO JournalEncouragedbioRxiv
Nature ImmunologyAllowedbioRxiv
ImmunityAllowedbioRxiv
Frontiers in ImmunologyAllowedbioRxiv / any
GastroenterologyAllowedmedRxiv / bioRxiv
GUTAllowedmedRxiv / bioRxiv
HepatologyAllowedmedRxiv / bioRxiv
Nature BiotechnologyAllowedbioRxiv / ChemRxiv
BloodAllowedbioRxiv / medRxiv
Journal of Clinical InvestigationAllowedbioRxiv / medRxiv
Lancet Infectious DiseasesAllowedmedRxiv
PLOS MedicineEncouragedmedRxiv / bioRxiv
BMC MedicineAllowedbioRxiv / medRxiv
BMJ OpenEncouragedmedRxiv
Science Translational MedicineAllowedbioRxiv / medRxiv

Practical Guidance

When to post a preprint

Most researchers post at the same time as or just before journal submission. This establishes priority without delaying the journal submission. Some post earlier to get community feedback before finalizing the manuscript. This works well for computational/methods papers where community scrutiny catches errors quickly.

Don't post until you have checked the target journal's current policy and any confidentiality, patent, sponsor, or clinical-safety constraints. A policy mismatch can complicate submission.

What to disclose at submission

Most journals that allow preprints ask you to disclose that a preprint exists in the cover letter or submission form. Include the preprint DOI. This is a transparency requirement, not a problem. Editors expect it.

If the manuscript is revised substantially after peer review, update the preprint to reflect the final version. Both bioRxiv and medRxiv allow version updates.

Practical note

Three preprint mistakes that still create avoidable submission friction

Posting before checking the target journal’s current policy and assuming every major title has the same stance.
Using the wrong server for a clinically sensitive manuscript when medRxiv screening is the better fit.
Forgetting to disclose the preprint DOI or link at submission even when the journal explicitly asks for it.

References

  1. Fraser N, Momeni F, Mayr P, Peters I. The relationship between bioRxiv preprints, citations and altmetrics. Quantitative Science Studies. 2020;1(2):618-638. [doi.org/10.1162/qss_a_00043 ↗]
  2. bioRxiv. About bioRxiv: the preprint server for biology. Cold Spring Harbor Laboratory. Retrieved February 2026. [biorxiv.org ↗]
  3. medRxiv. About medRxiv: the preprint server for health sciences. Cold Spring Harbor Laboratory / BMJ / Yale. Retrieved February 2026. [medrxiv.org ↗]
  4. ASAPbio. Preprint FAQ for researchers and journals. Retrieved February 2026. [asapbio.org ↗]
  5. SHERPA/RoMEO. Publisher copyright policies and self-archiving database. Jisc. Retrieved February 2026. [sherpa.ac.uk/romeo ↗]
  6. National Institutes of Health. (2017). Reporting preprints and other interim research products. [grants.nih.gov ↗]
  7. Journal of Clinical Investigation. (2026). About the journal: preprint server and institutional repository posting. [jci.org ↗]
Data note: Preprint policies are a February 2026 snapshot from individual journal author instructions and publisher policy pages; the JCI record was rechecked in September 2026. Policies change, so always verify the target journal's current author guidelines before posting. For detailed journal-by-journal policies, SHERPA/RoMEO is a useful policy directory. For accuracy corrections or updates, contact hello@manusights.com.

Cite this resource

Citation formats

Free to use and cite, with attribution. See the reuse policy for what you may republish.

APA
Manusights. (2026). Preprints in biomedicine: bioRxiv, medRxiv, and journal preprint policies (Dataset snapshot February 2026; JCI rechecked September 2026). https://manusights.com/resources/preprint-guide
MLA
Manusights. "Preprints in Biomedicine: bioRxiv, medRxiv, and Journal Preprint Policies." Manusights, dataset snapshot Feb. 2026; JCI rechecked Sept. 2026, manusights.com/resources/preprint-guide.
Vancouver
Manusights. Preprints in biomedicine: bioRxiv, medRxiv, and journal preprint policies [Internet]. Dataset snapshot Feb 2026; JCI rechecked Sep 2026. Available from: https://manusights.com/resources/preprint-guide

Related guides in this collection

Frequently Asked Questions

Does posting a preprint count as prior publication?

Many journals treat a preprint as a public draft rather than prior journal publication, but the policy belongs to the target journal and can change. This table is a February 2026 policy snapshot, with the JCI record rechecked in September 2026. Consult current author instructions or contact the journal before posting, particularly when a submission has clinical, confidentiality, patent, or sponsor constraints.

Should I post to bioRxiv or medRxiv?

Use bioRxiv for basic life sciences research: molecular biology, cell biology, genetics, neuroscience, immunology, biochemistry, and genomics. Use medRxiv for clinical medicine, epidemiology, public health, and research involving patient data or health outcomes. When in doubt, check which server your target journal recommends - many (like NEJM and JAMA) specify medRxiv for clinical manuscripts.

Will posting a preprint hurt my chances of journal acceptance?

No. There is no evidence that preprint posting reduces acceptance rates. Most top journals (Nature, Science, Cell, NEJM, JAMA, Lancet) explicitly allow and some actively encourage preprints. Editors evaluate the manuscript on its scientific merit, not on whether a preprint exists. Some journals - including eLife and PLOS ONE - have formal direct submission pathways from bioRxiv, treating preprint posting as a positive signal.